Swedish Orphan Biovitrum AB (1SOBI)
MTA
41.70
0.00 (0.00%)
Closed
Oct 2, 2026
Day's Range
41.7041.70
52 wk Range
26.5242.24
Financial Statements - 1SOBI - Swedish Orphan Biovitrum AB
Revenue
28.23B▲ 8.5%
Net Income
476.00M▼ 87.7%Net Margin 1.7%
EBITDA
10.93B▲ 17.2%
Free Cash Flow
5.41B▲ 23.5%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 28.23B | 26.02B |
| Cost of Goods | 6.25B | 5.78B |
| Gross Profit | 21.98B | 20.24B |
 Operating Expense | - | - |
| Operating Income | 922M | 5.61B |
| Non-Operating Interest | - | - |
| Other Income Expense | - | - |
| Pre Tax Income | 34M | 4.40B |
| Income Tax | -442M | 528M |
| Net Income | 476M | 3.87B |
| EPS Basic | 1.39 | 11.37 |
| EPS Diluted | 1.37 | 11.24 |
| Basic Shares Outstanding | 344.29M | 341.72M |
| Diluted Shares Outstanding | 344.29M | 341.72M |
| Ebit | 836M | 5.64B |
| Ebitda | 10.93B | 9.32B |
| Net Income Continuous Operations | 34M | 4.40B |
| Minority Interests | 2M | 6M |
| Preferred Stock Dividends | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
